Cellics Therapeutics, Inc.
Cellics Therapeutics is a company focused on developing novel therapeutics to address complex biology related to inflammation and immunology. Their mission is to create innovative solutions for significant unmet medical needs in these areas.
Industries
biotechnology
health-care
therapeutics
Nr. of Employees
small (1-50)
Cellics Therapeutics, Inc.
11588 Sorrento Valley Rd., Suite #20, San Diego, CA 92121
Patents
Use of nanoparticles coated with red blood cell membranes to treat hemolytic diseases and disorders
US-11110127-B2
View DetailsUse of nanoparticles coated with red blood cell membranes to enable blood transfusion
US-10434070-B2
View Details
Use of nanoparticles coated with red blood cell membranes to treat hemolytic diseases and disorders
US-11110127-B2
View DetailsUse of nanoparticles coated with red blood cell membranes to enable blood transfusion
US-10434070-B2
View DetailsProducts
CTI-005
A Red Blood Cell Nanosponge designed to treat Methicillin-resistant Staphylococcus Aureus (MRSA) pneumonia by absorbing and neutralizing bacterial toxins.
CTI-111
A Macrophage Nanosponge aimed at treating sepsis by absorbing and neutralizing inflammatory cytokines to control inflammation.
Cellular Nanosponges
Nanoparticles coated with cell membranes to bind and neutralize harmful agents like bacterial toxins, cytokines, and viruses.
CTI-005
A Red Blood Cell Nanosponge designed to treat Methicillin-resistant Staphylococcus Aureus (MRSA) pneumonia by absorbing and neutralizing bacterial toxins.
CTI-111
A Macrophage Nanosponge aimed at treating sepsis by absorbing and neutralizing inflammatory cytokines to control inflammation.
Cellular Nanosponges
Nanoparticles coated with cell membranes to bind and neutralize harmful agents like bacterial toxins, cytokines, and viruses.
Expertise Areas
- Inflammation biology
- Immunology therapeutics
- Therapeutic platform development
- Early-stage biotech development
Key Technologies
- Therapeutics platform
- Platform-based drug discovery
- Immunology-focused therapeutic discovery